ABSTRACT. Nutrient effects on cholesterol fractional synthesis rates (FSR) in infancy by stable isotope determination have not been studied. We hypothesized that FSR is significantly reduced with high dietary cholesterol and phytoestrogen intake and increased with low dietary cholesterol and phytoestrogen intake. We prospectively studied 33 term male infants exclusively fed human milk (high cholesterol, low phytoestrogen, n = 12), cow milk-based formula (low cholesterol, low phytoestrogen, n = 8), soy milk-based formula (zero cholesterol, high phytoestrogen, n = 7), or soy milk-based formula modified to contain cholesterol (low cholesterol, high phytoestrogen, n = 6) during the first 4 mo of life. Cholesterol FSR was determined from rate of incorporation of deuterium into erythrocyte membrane cholesterol, and urinary isoflavone excretion (an index of dietary phytoestrogen exposure) was measured by gas chromatography-mass spectrometry. Significant differences in cholesterol FSR were found. FSR (%Id) was lowest in human milk (2.62 f 0.38), highest in soy milk-based formula (9.40 f 0.51), and intermediate in cow milk-based and modified soy milk-based formula (6.90 f 0.48 and 8.03 f 0.28, respectively), p < 0.0001.
Cholesterol FSR was significantly lower in modified soy milk-based compared with soy milk-based formula, p < 0.05. We also show for the first time that dietary phytoestrogens are absorbed and excreted by the infant fed soy protein-based formula. Urinary isoflavone excretion was inversely related to cholesterol FSR, but it was not significantly related to serum cholesterol concentration. We conclude that the type of infant nutrition and dietary cholesterol are major factors influencing cholesterol fractional synthesis rates in infancy. (Pediatr Res 35: 135-140.1994) Abbreviations FSR, fractional synthesis rate HUM, human milk COW, cow milk-based formula SOY, soy milk-based formula MSOY, modified soy milk-based formula In adults. a high cholesterol intake inhibits endogenous cholesterol synthesis (I). However. the influence of nutrition on cholesterol metabolism in early life is largely unstudied. HUM contains a relatively large concentration of dietary cholesterol (2.59-3.88 mmol/L). By contrast. COW have low concentrations of cholesterol (0.28-0.85 mmol/L), and SOY contain no cholesterol. Differences in dietary cholesterol intake by infants may affect endogenous cholesterol FSR. and this rate may have relevance to cholesterol metabolism later in life (2. 3). T o our knowledge. no studies have been published on the effects of a diet completely devoid of cholesterol on endogenous cholesterol synthesis in human beings. The cholesterol-lowering effect of soy protein foods. although not well understood. is well established in infants and adults. Soy protein contains significant amounts of nonsteroidal estrogen analogues of the isoflavone class (4, 5) and it has been suggested that ingestion of these phytoestrogens may also play a role in cholesterol homeostasis (4).
A few studies of sterol balance in small (n = 5-10) and heterogenous (3-19 m o old) populations (6-9) have been conducted in infants. However, no in visa studies have been conducted on cholesterol synthesis rates using stable isotope techniques in a homogenous human infant population. The relationships between dietary cholesterol, phytoestrogen intake. serum cholesterol concentration, and endogenous cholesterol synthesis rates in infants have not been previously studied.
We therefore conducted a prospective. partially randomized. controlled study evaluating the effects of infant nutrition on cholesterol synthesis rates to determine whether cholesterol synthesis rates are influenced by cholesterol intake. We hypothesized that cholesterol synthesis rates will be negatively correlated with dietary cholesterol intake: thus. FSR will be lowest in infants fed HUM, highest in infants fed SOY, and intermediate in infants fed COW. A fourth group of infants fed MSOY. formulated to contain the same amount of cholesterol as COW, was included to determine whether the cholesterol component could be specifically responsible for alterations in cholesterol synthesis rates. As an ancillary hypothesis, we theorized that the high phytoestrogen content of SOY and MSOY (reflected by urinary isoflavone excretion) will contribute to an inhibition of cholesterol synthesis and, therefore. lower serum cholesterol concentrations in infants fed these formulas.
MATERIALS A N D M E T H O D S
Stlrdj3populution. Thirty-nine healthy Caucasian male infants who were full term, appropriate for gestational age, and had no known parental history of hypercholesterolemia or hypertriglyceridemia were recruited from the normal newborn nurseries of the University Hospital of Cincinnati and other area hospitals. Thirteen infants exclusively breastfed for the first 4 mo of life comprised the HUM-fed group. Twenty-six infants comprised the formula groups. Twenty of these infants were randomized to receive either COW (Similac with Iron, 20 cal/ounce; Ross Laboratories, Columbus, OH) (n = 10) or SOY (Isomil with Iron, 20 cal/ounce; Ross Laboratories, Columbus, OH) (n = 10). The last six formula-fed infants were assigned to receive MSOY. specially formulated to contain a cholesterol content (0.28 mmol/L) similar to that of COW. Assignment (rather than randomization) was due to initial delay in the availability of modified formula. The compositions of the different formulas are summarized in Table 1 . All infants received their assigned formula within the first 3 to 7 d of life. Formula was provided free to the formula-fed infants for the entire duration of the study to ensure compliance. The study was approved by the institutional review boards of all the involved hospitals, and informed consent was obtained before enrollment of the infants.
Thirty-three infants completed the study (HUM, n = 12; COW, n = 8; SOY, n = 7; MSOY, n = 6). One infant from the HUM group was eliminated from the study because the mother had stopped breastfeeding within 4 wk; two formula-fed infants (one from the COW group and one from the SOY group) were excluded from the study because of formula intolerance; and one infant from the COW group and two infants from the SOY group were lost to follow-up.
Mothers from the four groups were required to keep 3-d diet records for each month until the testing period at 4 mo. Mothers recorded information regarding the frequency of breastfeeding, the volume of supplemental COW given per day (Similac with Iron), and the volume of formula per day in the formula groups. By design, other forms of nutrition such as cereal were not allowed (except for multivitamins).
Cholesterol synthesis rates and urinary isoflavone excretion were determined at 4 mo of age. The age 4 mo was chosen because infants in the first 4 mo of life generally received exclusively human milk or formula (lo), so little potential existed for interference from other diets. Thus, differences in FSR, lipid profiles, and urinary isoflavone excretion could be specifically attributed to the type of milk consumed. Measurements were performed over a 4-d period. On d 1, a urine sample (approximately 15 mL) was obtained to determine baseline body water deuterium enrichment and urinary isoflavone concentrations. The infant was then orally given 500 mg/kg body weight of deuterium oxide (D20, 99.96% deuterium; Isotech Inc., Miamisburg, OH). On d 2 and 3, a blood sample for deuterium excess enrichment was obtained, after which 50 mg/kg body weight of D20 was given to maintain constant body water D 2 0 enrichment. On d 4, a final blood sample was obtained. No fasting period was required before phlebotomy, and all blood samples (8 mL each day on d 2-4) were drawn between 0900 h and 1 130 h.
Laboratory methods. Determinations of serum cholesterol and lipid profile were performed at the Medical Research Laboratories in Cincinnati, OH, with enzymatic techniques validated by the National Institutes of Health Lipid Research Clinics. Serum LDL cholesterol concentrations were calculated from serum total Determinations of cholesterol FSR were performed by the Stable Isotope Laboratory at the Children's Nutrition Research Center in Houston, Texas, using the methodologic procedure developed by Wong el al. (12) . FSR was determined from the rate of incorporation of deuterium into red blood cell membrane cholesterol. Briefly, the analytical procedure for FSR involves lipid extraction, purification of erythrocyte-free cholesterol by HPLC, conversion of cholesterol to carbon dioxide and water by combustion, reduction of the latter to hydrogen, and. finally. analysis of deuterium enrichment using gas/isotope ratio mass spectrometry (1 2). To calculate FSR, an exponential model using CONSAM, a compartmental modeling program from the National Institutes of Health (12a), was used. with the following formula:
where EBw is the deuterium enrichment in body water, K is the FSR in %/day, and T is the time in days.
Mean baseline deuterium enrichment in erythrocyte membrane cholesterol determined in 13 other normal infants from Cincinnati was used for the baseline value (0.01 184 f 0.004 atom %). The constant 0.4783 is the fraction of hydrogen atoms incorporated into the cholesterol molecule (22146) from body water. The coeficient of variation by this method ranged from 1 1 to 50%; higher coefficients of variation occur at low FSR as a result of reduced precision in isotope measurement because of minimal incorporation of deuterium into cholesterol from body water.
Urinary isoflavone excretion, specifically equol, daidzein, genistein, and total isoflavones (calculated as the sum of the three metabolites), were determined by mass spectrometry using previously described techniques (4, 5). Isoflavones and their conjugates were quantitatively extracted from urine by liquid-solid extraction, isolated by lipophilic gel chromatography before conversion to the volatile trimethylsilyl ethers, and analyzed by selected ion monitoring gas chromatography-mass spectrometry.
Statistical ana1.vsis. The statistical analysis system of Macintosh JMP, developed by the SAS Institute, Inc. (Cary, NC) was used for data management and analysis. One-way analysis of variance was used to test differences between groups. When values were normally distributed (lipid profiles and FSR), TukeyKramer method for multiple comparisons was used to determine differences between pairs of groups. Results for urinary isoflavones were log-transformed to approximate a gaussian distribution before testing for differences between groups. General linear models were used to determine correlations between the outcome variable (FSR) and the independent variables. A nonparametric test for ordered alternatives was used to determine correlations between quantity of cholesterol intake and FSR (1 3). Statistical significance was considered for p values less than 0.05.
RESULTS
Results are presented as mean + SEM. Demographic data are summarized in Table 2 . No significant differences were seen in birth weight and weight, length, and ponderal index at 4 mo among groups. No significant differences were observed in volume of milk intake among the formula groups as determined from dietary records.
Serum cholesterol and LDL cholesterol concentrations were highest in HUM, intermediate in COW and MSOY, and lowest in SOY, and were significantly different among groups (Table  3) . No differences were observed in serum HDL cholesterol and triglyceride concentrations among groups.
Deuterium enrichment of body water and erythrocyte cholesterol are shown in Figure 1 . No difference was seen in deuterium enrichment in body water among groups. Cumulative erythrocyte cholesterol enrichment was consistently lowest in HUM, Differences in FSR among the four groups were highly significant (Table 3) . FSR of HUM was significantly lower compared with all other groups. FSR of SOY was significantly higher than that ofCOW and MSOY, whereas FSR did not differ significantly between COW and MSOY. By nonparametric test for ordered alternatives. quantity of dietary cholesterol intake was significantly and negatively associated with FSR ( p = 0.0001). Correlation and p values were unchanged even when data from four infants (three from HUM and one from COW) with high serum cholesterol and triglyceride concentrations were excluded from the analysis. Combining all groups. a significant negative correlation existed between serum total cholesterol concentration and FSR ( r = -0.59. p < 0.005), and between serum LDL-cholesterol concentrations and FSR ( r = -0.67. p < 0.005) (Fig. 2) .
Total and individual urinary isoflavone excretion for 31 infants are presented in Figure 3 . Equol excretion was similar among the groups. However. urinary daidzein. genistein. and total isoflavone excretion differed significantly among groups. being low in HUM and COW and high in SOY and MSOY. To estimate the effect of dietary phytoestrogens on cholesterol FSR, we used a multiple regression analysis model controlling for group effect (because groups differed not only in quantity of dietary phytoestrogen but also in quantity of dietary cholesterol). Applying this model. we found that FSR was negatively associated with total urinary isoflavone excretion. p = 0.05. Serum cholesterol concentrations were not significantly associated with urinary isoflavone excretion. DISCUSSION T o our knowledge. only four previous cholesterol balance studies related to diet in infants have been reported. Using traditional balance techniques. researchers have estimated that endogenous cholesterol synthesis ranges from 0 to 40 mg/kg/d in infants on various diets (6-9). Conclusions from these studies may be limited by small sample size, implementation in nonhomogenous populations. and problems associated with balance studies. such as dependence on completeness of stool collection.
In our study. we minimized some of these problems by con- ducting the study prospectively and in a well-controlled population of 4-mo-old Caucasian males fed four distinct diets. Furthermore, endogenous cholesterol synthesis rates were more specifically determined with stable isotopes by measuring the incorporation of deuterium into erythrocyte membrane cholesterol.
Endogenous cholesterol synthesis determinations based on deuterium incorporation was first described by Rittenberg and Schoenheimer (14) and later modified by others (12, 15). The methodologic procedure is based on previous studies using tritiated water (16-18), and the interpretation of results depends on three assumptions (19). First, a constant fraction of the deuterium atoms in newly synthesized cholesterol is derived from deuterium in the body water pool. Because water freely and rapidly diffuses across cell membranes, plasma water deuterium concentration provides a measure of precursor enrichment, and deuterium enrichment of the newly synthesized cholesterol molecules corresponds to enrichment of the central pool (M l), which includes the liver, plasma, and intestine (20) . Second, within the central pool, rapid movement of newly synthesized cholesterol from the liver to plasma lipoproteins and then to cell membranes occurs, and therefore the deuterium content of erythrocyte membranes reflects newly synthesized cholesterol (21) . Third, deuterium uptake by cell membranes represents synthesis from the central pool only, and it does not represent influx of newly formed cholesterol from other pools or synthesis by erythrocytes. On the basis of these assumptions, it is believed that the stable isotope method provides a more reliable measurement of cholesterol synthesis compared with traditional balance techniques (1 7).
Our group has modified and adapted the methodologic procedure for use in human infants by determining FSR using erythrocyte membrane cholesterol (rather than plasma free cholesterol). The validity of determining cholesterol synthesis rates in erythrocytes rather than from plasma cholesterol is supported by our preliminary studies wherein we performed extensive kinetic simulations of the central pool defined by other investigators (20, 22) . Results of these studies indicate that any of the components of the central pool (e.g. plasma or red cell membrane) may serve as valid surrogates for the whole pool (unpublished observations). Additionally, it has been recently demonstrated in human adults that by 24 h after deuterium loading, cholesterol synthesis rates calculated from deuterium uptake by erythrocyte membrane cholesterol are similar to those calculated from plasma cholesterol enrichment (23) . Consequently, we have been able to use relatively small volumes of blood (8 mL every 24 h for 3 d compared with 20 to 120 mL every 24 h for 2 d). Thus, in this study, FSR is expressed as the rate of entry of deuterium into erythrocyte membrane cholesterol during the study period, calculated using the equation given earlier.
Another factor that may affect FSR determinations is differences in the natural abundance of deuterium within erythrocytes based on diet, age, and geographic location. In this study, baseline blood samples were not directly collected from study infants so that the number of blood draws and the amount of blood taken from these infants would be minimized. Rather, we measured the natural abundance of deuterium in erythrocyte cholesterol in 13 other 4-to 6-mo-old normal infants in the Cincinnati area.
The results were as follows: all infants, 0.01 18 + 0.0004 atom %; three infants on HUM. 0.01 17 + 0.0002 atom %; five infants on COW, 0.01 17 + 0.0002 atom %; and five infants on SOY, 0.0 120 + 0.0005 atom %. Individual baseline natural abundance determinations for each infant would be ideal, but limitations on blood sampling necessitated this approach.
Plasma water deuterium enrichment was used to compute an index of cholesterol precursor enrichment in the central pool for
